Source comparison
Quickcomparison
Dose Range BPC-157 250–500 mcg TB-500 2–5 mg Frequency Once daily Twice weekly Administration Subcutaneous injection Cycle Length 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Strong preclinical (extensive animal studies) Moderate human trials (Pha
This comparison does not assign a generated winner or score.
- Dose Range
- BPC-157
- 250–500 mcg
- TB-500
- 2–5 mg
- Frequency
- Once daily
- Twice weekly
- Administration
- Subcutaneous injection
- Cycle Length
- 4-6 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Strong preclinical (extensive animal studies)
- Moderate human trials (Phase 1-2)
- Efficacy